DaBomb Protein Biotech Corp. (TPEX:6578)
Taiwan · Delayed Price · Currency is TWD 16.30
+0.30 (1.88%)
May 20, 2026, 11:50 AM CST
DaBomb Protein Biotech Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -65.89 | -69.34 | 11.64 | -57.03 | -44.66 | -62.45 |
Depreciation & Amortization | 44.17 | 41 | 13.65 | 21.62 | 26.74 | 25.99 |
Other Amortization | 0.02 | 0.02 | 0.06 | 0.1 | 0.25 | 0.25 |
Loss (Gain) From Sale of Assets | 0.09 | 0.16 | -0.04 | 25.59 | -0.05 | - |
Asset Writedown & Restructuring Costs | 40.65 | 40.65 | - | - | - | - |
Loss (Gain) From Sale of Investments | - | - | 0.02 | 0.07 | -0.14 | 0.04 |
Stock-Based Compensation | - | -0.04 | 0.36 | 1.79 | 2.81 | 6.04 |
Other Operating Activities | 1.82 | 4.59 | 4.87 | 3.66 | -2.31 | -11.57 |
Change in Accounts Receivable | -15.01 | -7.69 | 18.27 | -14.06 | 18.99 | -6.36 |
Change in Inventory | -0.18 | 14.4 | -13.58 | 32.18 | -14.84 | 17.36 |
Change in Accounts Payable | 10.33 | -0.9 | 4.76 | -19.3 | 17.86 | -12.41 |
Change in Unearned Revenue | 0.86 | - | -0.23 | -2.17 | 2.4 | - |
Change in Other Net Operating Assets | -2.73 | -6.2 | 7.78 | 14.05 | 12.65 | -1.15 |
Operating Cash Flow | 14.13 | 16.65 | 47.55 | 6.51 | 19.71 | -44.25 |
Operating Cash Flow Growth | -61.26% | -65.00% | 630.92% | -66.98% | - | - |
Capital Expenditures | -17.79 | -37.69 | -30.24 | -18.87 | -19.99 | -332.09 |
Sale of Property, Plant & Equipment | 0.02 | 0.02 | 0.04 | 0.75 | 0.05 | - |
Sale (Purchase) of Intangibles | - | - | -0.08 | - | -0.16 | - |
Investment in Securities | 13.2 | 22.92 | -2 | -12.55 | 32.89 | -21.82 |
Other Investing Activities | 0.7 | 0.33 | 0.81 | -1.22 | 0.18 | -28.83 |
Investing Cash Flow | -3.88 | -14.42 | -31.48 | -31.89 | 12.96 | -382.75 |
Short-Term Debt Issued | - | 226.1 | 238.56 | 457.08 | - | - |
Long-Term Debt Issued | - | - | - | 40 | 59.45 | 621.57 |
Total Debt Issued | 196 | 226.1 | 238.56 | 497.08 | 59.45 | 621.57 |
Short-Term Debt Repaid | - | -288.1 | -240.56 | -460.08 | -66 | -46.5 |
Long-Term Debt Repaid | - | -32.07 | -103.2 | -68.04 | -113.9 | -225.53 |
Total Debt Repaid | -308.88 | -320.17 | -343.76 | -528.12 | -179.9 | -272.03 |
Net Debt Issued (Repaid) | -112.88 | -94.07 | -105.2 | -31.04 | -120.45 | 349.54 |
Issuance of Common Stock | - | - | - | 279.6 | 86.3 | 13.2 |
Common Dividends Paid | -28.78 | -28.78 | -34.55 | -39.71 | - | -6.03 |
Financing Cash Flow | -141.66 | -122.84 | -139.75 | 208.86 | -34.15 | 356.71 |
Foreign Exchange Rate Adjustments | -1.23 | -0.8 | -2.73 | 1.34 | -0.47 | 1.82 |
Net Cash Flow | -132.64 | -121.42 | -126.4 | 184.81 | -1.96 | -68.47 |
Free Cash Flow | -3.67 | -21.04 | 17.32 | -12.37 | -0.29 | -376.35 |
Free Cash Flow Margin | -1.14% | -6.80% | 5.13% | -3.22% | -0.07% | -79.97% |
Free Cash Flow Per Share | -0.05 | -0.29 | 0.24 | -0.23 | -0.01 | -11.59 |
Cash Interest Paid | 3.12 | 3.12 | 4.03 | 5.08 | 3.1 | 3.62 |
Cash Income Tax Paid | 0.14 | 0.14 | 0.39 | 0.38 | 0.1 | 3.21 |
Levered Free Cash Flow | 332.91 | 263.76 | 8.9 | -300.23 | 37.17 | -371.56 |
Unlevered Free Cash Flow | 334.46 | 265.68 | 12.15 | -295.08 | 41.28 | -368.7 |
Change in Working Capital | -6.74 | -0.4 | 16.99 | 10.7 | 37.06 | -2.55 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.